The World Health Organization said on Wednesday it has listed two additional mpox in-vitro diagnostic tests for emergency use ...

Cepheid and Roche Diagnostics Tests Provide Rapid and Decentralized Detection Options as Mpox Cases Continue to Rise ...

WHO has listed two additional mpox in vitro diagnostics under its Emergency Use Listing procedure to enhance quality-assured ...

As part of ongoing efforts to enhance quality-assured testing options, the World Health Organization (WHO) has listed two ...

The World Health Organization (WHO) has listed additional mpox diagnostic tests for emergency use. The polymerase chain reaction (PCR) test remains the gold standard. On October 25, WHO listed Xpert ...

WHO's EUL process is based on a thorough evaluation of quality, safety, and performance data, ensuring compliance with ...

The organization also listed another PCR-based option, the cobas MPXV assay developed by Roche Molecular Systems, on October 14. Reuters Last Updated : 30 October 2024, 16:05 IST ...

The World Health Organization (WHO) has reclassified Mpox as a global public health emergency due to a sharp rise in cases in the Democratic Republic of Congo (DRC) and surrounding regions.

Another PCR-based option, the cobas MPXV assay, developed by Roche Molecular Systems, Inc., was listed on 14 October. It is ...